What is ResTORbio?
ResTORbio, operating under the brand Restore Beauty - Rethink Bio, is a company dedicated to the beauty and personal care industry. Their comprehensive product line encompasses skincare, haircare, makeup, and massage products, all designed to rejuvenate skin and hair. The company also provides beauty tips and reviews, aiming to empower consumers with information to enhance their beauty routines. By focusing on advanced skincare techniques and high-quality cosmetic products, ResTORbio caters to a discerning clientele seeking effective and informed beauty solutions. Their commitment to informative content and product comparisons positions them as a valuable resource for consumers navigating the beauty market.
How much funding has ResTORbio raised?
ResTORbio has raised a total of $65M across 2 funding rounds:
Series A
$25M
Series B
$40M
Series A (2017): $25M, investors not publicly disclosed
Series B (2017): $40M led by OrbiMed, Nest Bio Ventures, Fidelity Management & Research Company, Rock Springs Capital, and Quan Capital
Key Investors in ResTORbio
OrbiMed
OrbiMed Advisors LLC is a specialized investment firm with deep expertise in the healthcare sector, managing capital across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services. They support companies at various stages of development, from early-stage ventures to scaling organizations.
Fidelity Management & Research Company
Fidelity Investments is an international provider of financial services and investment resources, assisting individuals and institutions in meeting their financial objectives across various investment domains.
Rock Springs Capital
Rockspring is a Texas-based real estate firm with extensive experience in investing and brokerage services since 1993, focusing on the Texas Triangle across residential, retail, and industrial asset classes.
What's next for ResTORbio?
With the recent major strategic investment, ResTORbio is poised for accelerated expansion and product development. The substantial capital infusion, part of its enterprise-level funding, suggests a strategic focus on scaling operations, enhancing research and development, and potentially broadening its market reach. This backing is indicative of the company's strong market position and future growth prospects within the competitive beauty and skincare landscape. The company is likely to leverage this financing to further innovate its product offerings and strengthen its competitive advantage.
See full ResTORbio company page
